Management of Upper Respiratory Symptoms with Cough, Congestion, and Ear Fullness
Start empiric treatment with a first-generation antihistamine/decongestant (A/D) combination for presumed upper airway cough syndrome (UACS) while assessing for bacterial sinusitis. This symptom constellation—bronchial congestion, cough, ear fullness, and nasal drainage—most likely represents UACS (previously called postnasal drip syndrome), which is the most common cause of chronic cough 1.
Initial Assessment and Diagnosis
Your patient's ear fullness results from edema of the nasal mucosa causing eustachian tube occlusion, a hallmark of viral or inflammatory rhinitis 2. The key diagnostic question is whether this represents:
- Viral upper respiratory infection (most common—accounts for 98% of acute infectious rhinitis) 2
- Bacterial sinusitis (occurs in <2% of viral URI cases) 2
- Allergic or vasomotor rhinitis with secondary UACS
Critical distinguishing features for bacterial sinusitis include:
- Symptoms persisting beyond 7-10 days
- Mucopurulent (cloudy, colored) nasal discharge
- Facial pain or pressure
- Vestibular crusting
- Note: Fever may be absent, and cough can be nonproductive 2
Treatment Algorithm
For Presumed Viral URI or UACS (Most Likely Scenario)
First-line empiric therapy:
- First-generation antihistamine/decongestant combination twice daily 1
- Continue for 1-2 weeks to assess response
- Avoid antibiotics—they provide minimal benefit (0.5 days reduction in cough duration) while exposing patients to adverse effects 3
Important caveat: If using nasal decongestant sprays (oxymetazoline), limit to 5 days maximum to prevent rhinitis medicamentosa 1. One nostril at a time weaning may be necessary if rebound congestion develops 1.
If Bacterial Sinusitis is Suspected
Proceed with sinus imaging if the patient fails to respond to A/D therapy, as chronic sinusitis can present with minimal or nonproductive cough and none of the typical acute findings 1.
If bacterial sinusitis confirmed, treat with:
- Antibiotic effective against S. pneumoniae, H. influenzae, and M. catarrhalis (common organisms) 1
- Intranasal corticosteroids to decrease inflammation (proven helpful) 1
- Nasal decongestant for maximum 5 days 1
For chronic sinusitis (if symptoms persist):
- Minimum 3 weeks of appropriate antibiotic
- Minimum 3 weeks of oral A/D twice daily
- 5 days of nasal decongestant twice daily
- Continue intranasal corticosteroids for 3 months after cough resolves 1
For Nonallergic/Vasomotor Rhinitis Features
If the patient has predominantly clear rhinorrhea without purulence:
- Intranasal corticosteroids are first-line for both congestion and rhinorrhea 2
- Intranasal antihistamines may relieve congestion and rhinorrhea 2
- Intranasal anticholinergics specifically target rhinorrhea (less effect on congestion) 2
- Oral nonsedating antihistamines are NOT effective for nonallergic rhinitis 2
Common Pitfalls to Avoid
Don't prescribe antibiotics for acute bronchitis/viral URI without clear evidence of bacterial infection—this is self-limiting and resolves in 2-3 weeks 3
Don't use nasal decongestant sprays beyond 5 days—this causes rebound congestion requiring difficult weaning 1
Don't assume all cough with nasal symptoms needs antibiotics—response to specific therapy is the pivotal factor confirming UACS diagnosis 1
Don't overlook congestive heart failure as a cause of progressive dyspnea and cough, especially in patients with known heart disease 4
When to Refer or Escalate
Consider specialist consultation if:
- Symptoms persist despite 2-3 weeks of appropriate empiric therapy
- Complications develop (recurrent sinusitis, otitis media)
- Unilateral, bloody, or malodorous discharge (suggests foreign body or other pathology) 2
- Quality of life significantly impaired (sleep disturbance, work/school performance) 2
The diagnosis of UACS-induced cough requires considering symptoms, physical findings, imaging when indicated, and ultimately response to therapy—not any single test 1. Patient education about expected symptom duration (2-3 weeks for viral illness) is essential to reduce unnecessary antibiotic use 3.